3,835 Shares in CME Group Inc. $CME Purchased by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. acquired a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 3,835 shares of the financial services provider’s stock, valued at approximately $1,057,000.

Several other large investors have also recently bought and sold shares of CME. Webster Bank N. A. raised its stake in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the last quarter. Highline Wealth Partners LLC increased its holdings in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the period. Sagard Holdings Management Inc. bought a new position in CME Group during the 2nd quarter worth $30,000. Ransom Advisory Ltd acquired a new position in CME Group during the 1st quarter worth about $31,000. Finally, Trifecta Capital Advisors LLC grew its position in shares of CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after buying an additional 42 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Performance

Shares of CME Group stock opened at $272.18 on Tuesday. The business has a 50-day simple moving average of $272.06 and a 200 day simple moving average of $272.13. CME Group Inc. has a one year low of $224.62 and a one year high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $98.15 billion, a price-to-earnings ratio of 26.37, a PEG ratio of 4.08 and a beta of 0.28.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the company earned $2.68 earnings per share. The company’s quarterly revenue was down 3.0% on a year-over-year basis. On average, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Insider Buying and Selling at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard bought 262 shares of the stock in a transaction that occurred on Thursday, September 25th. The stock was acquired at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the acquisition, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders sold 26,392 shares of company stock worth $7,104,984. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Rothschild & Co Redburn raised their price objective on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. Keefe, Bruyette & Woods raised their price target on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Bank of America boosted their price target on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Finally, Royal Bank Of Canada lifted their target price on shares of CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a research note on Friday, December 5th. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $290.00.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.